US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Temasek Holdings

1,236.87

+1.480.12%

Number of Gainers:45

Number of Losers:39

Number of Flat:2

PE:- -

High:1,251.54

Open:1,235.39

Low:1,223.49

Close:1,235.39

Loading ...

Uber Bid to Separate Lawsuits Over Alleged Sexual Assaults Rejected by Federal Appeals Court

MT Newswires Live

Press Release: Illumina addresses recent developments in China

BRIEF-Coherus BioSciences Q4 Net Income USD -50.696 Million

Coherus BioSciences Inc - Post Divestiture Cash Expected at $250 Million, Headcount Reduced by 30%

THOMSON REUTERS

Coherus BioSciences Inc -Approximately 50 Employees Associated With Udenyca Are Expected to Transfer to Accord Biopharma

THOMSON REUTERS

Coherus BioSciences Inc -Qtrly Shr Loss $0.44

THOMSON REUTERS

Coherus BioSciences Q4 Net Income USD -50.696 Million

THOMSON REUTERS

Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update

Illumina Inc - Cost Reduction Program Includes Optimizing Stock-Based Compensation and Non-Labor Spending

THOMSON REUTERS

Illumina Inc FY2025 Shr View $4.52 -- Lseg Ibes Data

THOMSON REUTERS

Illumina Addresses Recent Developments in China

THOMSON REUTERS

Illumina Inc - Company Is Instituting an Incremental Approximately $100 Mln Cost Reduction Program for Fiscal 2025

THOMSON REUTERS

Illumina Inc: Remain Focused on Achieving High-Single-Digit Revenue Growth by 2027

THOMSON REUTERS

Illumina Inc: New Fiscal 2025 Guidance Provides for Limited Further Earnings Contribution From China

THOMSON REUTERS

Illumina Inc - Announces Fiscal Year 2025 Non-Gaap Diluted EPS of Approximately $4.50

THOMSON REUTERS

Illumina Is Lowering Its 2025 Guidance of $4.50 Adjusted Earnings per Share, at the Low End of the Range of $4.50 to $4.65 a Share Given Last Month- WSJ

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4535/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4535"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4535\",,,,,undefined,":{"symbol":"BK4535","market":"US","secType":"PLATE","nameCN":"Temasek Holdings","latestPrice":1236.8701,"timestamp":1741723199999,"preClose":1235.3864,"halted":0,"volume":738671251,"delay":0,"changeRate":0.001201,"change":1.483765,"pbRate":5.998041,"amount":73072478010.26042,"amplitude":0.022702,"prevYearClose":1309.0717,"fiveDayClose":1275.8163,"twentyDayClose":1360.4474,"turnoverRate":0.012535,"marketCap":8898721240499.125,"floatMarketCap":8277689553525.75,"peRate":32.812955},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4535\",,,,,undefined,":{"symbol":"BK4535","high":1251.5391,"amplitude":0.022702,"preClose":1235.3864,"low":1223.4937,"pbRate":"5.998041","latestPrice":1236.8701,"volume":738671251,"delay":0,"open":1235.3877,"prevYearClose":1309.0717,"prevWeekClose":1272.468,"prevMonthClose":1313.2322,"prevQuarterClose":1309.0717,"fiveDayClose":1275.8163,"twentyDayClose":1360.4474,"sixtyDayClose":1359.822,"secType":"PLATE","market":"US","turnoverRate":0.012535,"peRate":32.812955,"marketCap":8898721240499.125,"floatMarketCap":8277689553525.75,"timestamp":1741723199999,"nameCN":"Temasek Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4535\",,,,undefined,":{"bkCode":"BK4535","up":45,"down":39,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4535\",pageSize:16,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518032788","title":"Uber Bid to Separate Lawsuits Over Alleged Sexual Assaults Rejected by Federal Appeals Court","url":"https://stock-news.laohu8.com/highlight/detail?id=2518032788","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518032788?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:32","pubTimestamp":1741638765,"startTime":"0","endTime":"0","summary":"Uber Technologies'  attempt to stop the consolidation of sexual assault lawsuits by its customers from individual cases was rejected Monday by a federal appeals court in San Francisco on Monday.A three-judge panel for the US Court of Appeals for the Ninth Circuit turned down Uber's argument that the terms of use agreement for the company's app prohibits riders from taking part in \"coordinated\" or \"consolidated\" legal actions against the company.The US Judicial Panel on Multidistrict Litigation last year consolidated nearly 80 pending actions filed by Uber passengers in 13 judicial districts seeking compensation after alleging they were assaulted or harassed sexually by an Uber driver, contending the company did not do enough to protect them.The company challenged the decision to consolidate the cases, but the appeals court said the panel acted within its statutory authority by combining the lawsuits despite the user agreement prohibition.Uber did not immediately respond to a request fr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999014914.USD","SG9999014906.USD","LU1861214812.USD","LU0006306889.USD","LU0082616367.USD","LU1988902786.USD","LU0353189763.USD","BK4585","SG9999015952.SGD","SG9999018857.SGD","BK4503","US3Y.BOND","IE0002270589.USD","IE00B19Z3B42.SGD","SG9999017495.SGD","LU1814569148.SGD","US6M.BOND","LU1064131342.USD","US2Y.BOND","BK4230","SG9999014880.SGD","BK4536","SG9999015978.USD","BK4588","LU0642271901.SGD","IE00B7SZLL34.SGD","SG9999014898.SGD","BK4551","BK4505","LU1983260115.SGD","BK4535","LU0127658192.USD","LU2087625088.SGD","SGXZ31699556.SGD","SG9999015986.USD","BK4022","UBER","US7Y.BOND","IE00BZ199S13.USD","US12M.BOND","US10Y.BOND","LU0719512351.SGD","LU0106261372.USD","LU0353189680.USD","LU1861219969.SGD","LU1316542783.SGD","US5Y.BOND","US30Y.BOND","IE00B19Z3581.USD","BK4550"],"gpt_icon":0},{"id":"2518788977","title":"Press Release: Illumina addresses recent developments in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2518788977","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518788977?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:22","pubTimestamp":1741638120,"startTime":"0","endTime":"0","summary":"Announces Fiscal Year 2025 Non-GAAP Diluted EPS of Approximately $4.50. \"We remain focused on achieving high-single-digit revenue growth by 2027, while expanding our margins,\" said Jacob Thaysen, CEO of Illumina. \"We are confident in the large global market opportunity for our solutions, the strength of our business, and our strategy to continue to lead innovation in genomics and multiomics in support of our customers.\". Illumina also announced it expects Core Illumina fiscal 2025 non-GAAP diluted EPS of approximately $4.50. The company is instituting an incremental approximately $100 million cost reduction program for fiscal 2025. These savings would mitigate the impact of a range of potential scenarios for a reduction in revenue and related operating income from the company's Greater China business. The cost reduction program includes optimizing stock-based compensation and non-labor spending and accelerating certain productivity measures.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4534","BK4548","BK4588","BK4535","ILMN","BK4585"],"gpt_icon":0},{"id":"2518200433","title":"BRIEF-Coherus BioSciences Q4 Net Income USD -50.696 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200433","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518200433?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:13","pubTimestamp":1741637621,"startTime":"0","endTime":"0","summary":"Mar 10  - Coherus BioSciences Q4 pretax profit USD -50.696 million vs. IBES estimate USD -20.6 million.Q4 sales USD 53.933 million vs. IBES estimate USD 47.3 million. Q4 adjusted net income USD -32.5 million vs. IBES estimate USD -14.4 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nPLX57601D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2518420017","title":"Coherus BioSciences Inc - Post Divestiture Cash Expected at $250 Million, Headcount Reduced by 30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518420017","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518420017?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:12","pubTimestamp":1741637577,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nPLX57601D:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2518200257","title":"Coherus BioSciences Inc -Approximately 50 Employees Associated With Udenyca Are Expected to Transfer to Accord Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518200257?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:12","pubTimestamp":1741637577,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nPLX57601D:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2518007582","title":"Coherus BioSciences Inc -Qtrly Shr Loss $0.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2518007582","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518007582?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:12","pubTimestamp":1741637577,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nPLX57601D:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2518001762","title":"Coherus BioSciences Q4 Net Income USD -50.696 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2518001762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518001762?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:12","pubTimestamp":1741637577,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nPLX57601D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2518788325","title":"Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2518788325","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518788325?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:12","pubTimestamp":1741637520,"startTime":"0","endTime":"0","summary":"– UDENYCA divestiture on track with Special Meeting of Shareholders taking place March 11, 2025; transaction expected to close late in the first quarter or early in the second quarter of 2025 –。– Post divestiture expected cash of approximately $250 million, with cash runway exceeding two years; Company headcount to be reduced by approximately 30% –。– Catalyst-driven 2025/2026 with multiple clinical data readouts across the Company’s innovative oncology pipeline –。– Conference call today at 5:00 p.m. Eastern Time –。REDWOOD CITY, Calif., March 10, 2025  -- Coherus BioSciences, Inc. , today reported financial results for the fourth quarter and full year 2024 and provided an overview of recent business updates.“Upon the completion of the UDENYCA divestiture and pay-off of our significant debt and royalty obligations, we are projecting a cash position of approximately $250 million,\"continued Mr. Lanfear. “These efforts, combined with organizational streamlining, are expected to provide Cohe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coherus-biosciences-reports-fourth-quarter-201200398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CHSCO","BK4535","CHSCL","CR","BK4161","HCC","CHSCM","CHSCN","CHRS","ORR","BK4006","BK4139","BK4189"],"gpt_icon":0},{"id":"2518420090","title":"Illumina Inc - Cost Reduction Program Includes Optimizing Stock-Based Compensation and Non-Labor Spending","url":"https://stock-news.laohu8.com/highlight/detail?id=2518420090","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518420090?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:10","pubTimestamp":1741637409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT11Q:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","BK4585","BK4588","BK4548","BK4121","BK4535","ILMN"],"gpt_icon":0},{"id":"2518220097","title":"Illumina Inc  FY2025 Shr View $4.52 -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220097","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518220097?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:10","pubTimestamp":1741637409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT11Q:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILMN","BK4534","BK4535","BK4588","BK4121","BK4548","BK4585"],"gpt_icon":0},{"id":"2518200977","title":"Illumina Addresses Recent Developments in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518200977?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:10","pubTimestamp":1741637409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT11Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4535","ILMN","BK4534","BK4548","BK4121","BK4588"],"gpt_icon":0},{"id":"2518200971","title":"Illumina Inc - Company Is Instituting an Incremental Approximately $100 Mln Cost Reduction Program for Fiscal 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200971","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518200971?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:10","pubTimestamp":1741637409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT11Q:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4548","BK4534","ILMN","BK4585","BK4121","BK4535"],"gpt_icon":0},{"id":"2518200924","title":"Illumina Inc: Remain Focused on Achieving High-Single-Digit Revenue Growth by 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518200924?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:10","pubTimestamp":1741637409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT11Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4548","BK4585","BK4534","ILMN","BK4588","BK4121"],"gpt_icon":0},{"id":"2518200146","title":"Illumina Inc: New Fiscal 2025 Guidance Provides for Limited Further Earnings Contribution From China","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518200146?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:10","pubTimestamp":1741637409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT11Q:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4534","BK4121","ILMN","BK4588","BK4535","BK4548"],"gpt_icon":0},{"id":"2518143200","title":"Illumina Inc - Announces Fiscal Year 2025 Non-Gaap Diluted EPS of Approximately $4.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2518143200","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518143200?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:10","pubTimestamp":1741637409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT11Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4588","BK4534","BK4548","ILMN","BK4585","BK4121"],"gpt_icon":0},{"id":"2518207096","title":"Illumina Is Lowering Its 2025 Guidance of $4.50 Adjusted Earnings per Share, at the Low End of the Range of $4.50 to $4.65 a Share Given Last Month- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2518207096","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518207096?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:02","pubTimestamp":1741636958,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0NW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4534","BK4588","BK4535","BK4548","BK4585","ILMN"],"gpt_icon":0}],"pageSize":16,"totalPage":93,"pageCount":10,"totalSize":1481}]}}